Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer
To report the clinical outcomes and treatment-related toxicities after combined high-dose-rate (HDR) brachytherapy (BRT) with external beam radiotherapy (EBRT) for patients with clinically localised high-risk prostate cancer.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Iosif Strouthos, Georgios Chatzikonstantinou, Nikolaos Zamboglou, Natasa Milickovic, Sokratis Papaioannou, Dimitra Bon, Constantinos Zamboglou, Claus R ödel, Dimos Baltas, Nikolaos Tselis Tags: Original article Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Radiology | Toxicology